Position in TRDA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$394,407
-$281,873 QoQ
Shares Held
53,588
0.0% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. TRDA ranks #114 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $394,407 | 53,588 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $676,280 | 53,588 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $388,460 | 37,788 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $219,170 | 37,788 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $321,135 | 47,788 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $432,003 | 47,788 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $826,254 | 47,788 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $763,652 | 47,788 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,016,139 | 71,308 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,010,434 | 71,308 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,799,542 | 119,254 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,884,213 | 119,254 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $902,752 | 59,627 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $864,591 | 59,627 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $806,157 | 59,627 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $937,656 | 59,496 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $702,481 | 57,675 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $541,568 | 57,675 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $987,396 | 57,675 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||